Medicare Enrolled

Dr. Pooja Alloju, OD

Optometrist · Plano, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
6533 PRESTON RD STE 100, Plano, TX 75024
4696069686
In practice since 2021 (4 years)
NPI: 1407527443 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alloju from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alloju? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Alloju

Dr. Pooja Alloju is an optometrist in Plano, TX, with 4 years in practice. Based on federal Medicare data, Dr. Alloju performed 680 Medicare services across 592 unique beneficiaries.

Between the years covered by Open Payments, Dr. Alloju received a total of $2,433 from 23 pharmaceutical and/or device companies across 66 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optometrist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Alloju is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 4 years in practice▲ Top 17% volume in TX$ $2,433 industry payments

Medicare Practice Summary

Medicare Utilization ↗
680
Medicare services
Top 17% in TX for optometrist
592
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~170 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Eye exam, established patient, focused173$62$190
Comprehensive eye exam, established patient139$83$274
Retinal photography (fundus photo)130$27$84
Optic nerve imaging (OCT scan)51$23$79
Retinal imaging (OCT scan)46$28$83
Office visit, established patient (30-39 min)33$95$285
Ct scan of cornea31$26$74
Comprehensive eye exam, new patient28$94$310
Visual field test, extended26$42$134
Closure of tear duct opening using plug23$127$332
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,433
Total received (2021-2024)
Avg $608/year across 4 years
Top 21% in TX for optometrist
23
Companies
66
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,433 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,256
2023
$592
2022
$406
2021
$179

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb Americas Inc.
$728
Sun Pharmaceutical Industries Inc.
$288
Oyster Point Pharma, Inc.
$217
BIOTISSUE HOLDINGS INC.
$185
Johnson & Johnson Surgical Vision, Inc.
$122
Horizon Therapeutics plc
$119
GLAUKOS CORPORATION
$111
SUN PHARMACEUTICAL INDUSTRIES INC.
$106
Alcon Vision LLC
$96
Dompe US, Inc.
$70
Tarsus Pharmaceuticals, Inc.
$62
NOVARTIS PHARMACEUTICALS CORPORATION
$60
BIOTISSUE HOLDINGS, INC.
$43
ABBVIE INC.
$43
Harrow Eye, LLC
$36
Dexcom, Inc.
$23
Rayner Intraocular Lenses Limited
$21
Astellas Pharma US Inc
$21
Novartis Pharmaceuticals Corporation
$20
Alvogen Inc
$19
RxSight Inc
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Spark Therapeutics, Inc.
$12
Top 3 companies account for 50.7% of total payments
Associated products mentioned in payments ›
ALDEN SCLERAL ZENLENS · Cequa · Clareon · Dexcom G6 Transmitter · Izervay · JARDIANCE · KXL SYSTEM · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LUMIGAN · MIEBO · OXERVATE · Omidria · PROKERA · TECNIS IOL · TEPEZZA · TERIPARATIDE · TYRVAYA · VEVYE · VYZULTA · XDEMVY · XIIDRA · ZENLENS
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $358 per 100 Medicare services performed
Looking for a optometrist in Plano?
Compare optometrists in the Plano area by procedure volume, costs, and industry payment transparency.
Browse optometrists nearby

Geographic Context

Optometrists within 10 mi
788
Per 100K population
70.6
County median income
$117,588
Nearest hospital
CHILDRENS MEDICAL CENTER PLANO
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Alloju is a mixed practice specialist, with above-average Medicare volume (top 17% in TX), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Alloju experienced with eye exam, established patient, focused?
Based on Medicare claims data, Dr. Alloju performed 173 eye exam, established patient, focused services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alloju receive payments from pharmaceutical companies?
Yes. Dr. Alloju received a total of $2,433 from 23 companies across 66 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alloju's costs compare to other optometrists in Plano?
Dr. Alloju's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alloju) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →